Pharmacy Times November 16, 2023

Expert discusses changes health care professionals should know about drug coverage and out-of-pocket costs through the IRA

Pharmacy Times interviewed Bret Jackson, President, and CEO of the Economic Alliance for Michigan on the current landscape of the Inflation Reduction Act. Jackson underscores the cap on out-of-pocket costs for Medicare Part D and the changes that will go into effect in 2024. Jackson notes the timeline for additional drugs that will be chosen for price negotiation in the future.

Pharmacy Times

Can you introduce yourself?

Bret Jackson

Well, thanks for having me. My name is Brett Jackson. I’m President and CEO of the Economic Alliance for Michigan. I’m delighted to be able to join you today and talk about the Inflation...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Interview / Q&A, Medicare, Pharma, Pharma / Biotech, Trends
Related Articles:
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Prior authorizations, pharmacy transparency, vertical integration all part of the Medicare 2026 rule
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article